张彩霞,何红伟,邵荣光. 鞘氨醇激酶与肿瘤J. 药学学报, 2013,48(7): 971-978.
引用本文: 张彩霞,何红伟,邵荣光. 鞘氨醇激酶与肿瘤J. 药学学报, 2013,48(7): 971-978.
ZHANG Cai-xia, HE Hong-wei, SHAO Rong-guang. Sphingosine kinase 1 and tumorJ. 药学学报, 2013,48(7): 971-978.
Citation: ZHANG Cai-xia, HE Hong-wei, SHAO Rong-guang. Sphingosine kinase 1 and tumorJ. 药学学报, 2013,48(7): 971-978.

鞘氨醇激酶与肿瘤

Sphingosine kinase 1 and tumor

  • 摘要:

    鞘脂是细胞生物学功能的重要调控子。重要的鞘脂类分子有促细胞凋亡和抑制细胞增殖的神经酰胺 (ceramide, Cer) 和鞘氨醇 (sphingosine, Sph), 以及促细胞存活的鞘氨醇-1-磷酸 (sphingosine 1-phosphate, S1P)Cer/SphS1P之间形成鞘脂变阻器(sphingolipid-rheostat), 决定细胞的存活或死亡, 而鞘氨醇激酶 (sphingosine kinases, SphKs) Cer/SphS1P平衡的重要调控分子。本文综述了鞘氨醇激酶1 (sphingosine kinase 1, SphK1) 的生物学特性、其在肿瘤发生发展中的重要作用, 以及作为肿瘤治疗靶点的可能性。

     

    Abstract:

    Sphingolipids as an important regulator play a critical role in the cell biological functions.  Among them, ceramide (Cer) and sphingosine (Sph) induce apoptosis and inhibit cell proliferation; on the contrary sphingosine 1-phosphate (S1P) promotes cell survival and proliferation.  The balance between ceramide/sphingosine and S1P forms a so-called “sphingolipid-rheostat”, which decides the cell fate.  Sphingosine kinases, which catalyze the phosphorylation of sphingosine to S1P, are critical regulators of this balance.  Here, we review the role of sphingosine kinase 1 (SphK1) in regulating fundamental biological processes and tumorigenesis and the potential of SphK1 as a new target for cancer therapeutics.

     

/

返回文章
返回